Lycopene/tomato consumption and the risk of prostate cancer: A systematic review and meta-analysis of prospective studie

Journal of Nutritional Science and Vitaminology

Volumn 59, Issue 3, 2013, Pages 213-223

  Chen, Jinyao ^a   Song, Yang ^a   Zhang, Lishi ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Lycopene; Meta analysis; Prostate cancer; Systematic review; Tomato

Indexed keywords

LYCOPENE;

ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER THERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); FOLLOW UP; FOOD INTAKE; HUMAN; META ANALYSIS; PROSTATE CANCER; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TOMATO;

EID: 84880777927     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.59.213     Document Type: Article

References (33)

1. AIHW (Australian Institute of Health and Welfare) & AACR (Australasian Association of Cancer Registries). 2007. Cancer in Australia: an overview. 2006. Cancer series no. 37. cat. no. CAN 32. AIHW, Canberra.
2. Beebe-Dimmer JL, Wood DP, Gruber SB, Douglas JA, Bonner JD, Mohai C. 2004. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study. Urology 63: 282-287.
3. Chan JM, Elkin EP, Silva SJ, Broering JM, Latini DM, Carroll PR. 2005. Total and specific complementary and alternative medicine use in a large cohort of men with prostate cancer. Urology 66: 1223-1228.
4. Rackley JD, Clark PE, Hall MC. 2006. Complementary and alternative medicine for advanced prostate cancer. Urol Clin North Am 33: 237-246.
5. Byers T, Nestle M, McTiernan A, Doyle C, Currie-Williams A, Gansler T, Thun M. 2002. American Cancer Society. 2001. Nutrition and Physical Activity Guidelines Advisory Committee. American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention. CA Cancer J Clin 52: 92-119.
6. World Cancer Research Fund/American Institute for Cancer Research. 2007. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington, DC.
7. Kavanaugh CJ, Trumbo PR, Ellwood KC. 2007. The U.S. Food and Drug Administration's evidence-based review for qualified health claims: tomatoes, lycopene, and cancer. J Natl Cancer Inst 99: 1074-1085.
8. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzschee PC, Vandenbroucke JP. 2008. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61: 344-349.
9. Higgins JPT, Green S. 2008. Cochrane Collaboration. In: Cochrane Handbook for Systematic Reviews of Interventions. Wiley-Blackwell, Hoboken, NJ.
10. The Cochrane Collaboration. 2008. Review Manager (RevMan). The Nordic Cochrane Centre, Copenhagen.
11. Kirsh VA, Mayne ST, Peters U, Chatterjee N, Leitzmann MF, Dixon LB, Urban DA, Crawford ED, Hayes RB. 2006. A prospective study of lycopene and tomato product intake and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 15: 92-98.
12. Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM. 2010. Diet, supplement use, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Am J Epidemiol 172: 566-577.
13. Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. 2002. A prospective study of tomato products, lycopene, and prostate cancer risk. J Natl Cancer Inst 94: 391-398.
14. Schuurman AG, Goldbohm RA, Brants HA, Van den Brandt PA. 2002. A prospective cohort study on intake of retinal, vitamins C and E, and carotenoids and prostate cancer risk. Cancer Causes Control 13: 573-578.
15. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. 1995. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst 85: 1767-1776
16. Mills PK, Beeson WL, Phillips RL, Fraser GE. 1989. Cohort study of diet, lifestyle, and prostate cancer in adventist men. Cancer 64: 598-604.
17. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, Stampfer MJ. 1999. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59: 1225-1230.
18. Wu K, Erdman JW Jr, Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, DeGroff V, Willett WC, Giovannucci E. 2004. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev 13: 260-269.
19. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, Egevad L, Tjønneland A, Johnsen NF, Overvad K, Linseisen J, Rohrmann S, Boeing H, Pischon T, Psaltopoulou T, Trichopoulou A, Trichopoulos D, Palli D, Vineis P, Tumino R, Berrino F, Kiemeney L, Bueno-de-Mesquita HB, Quirós JR, González CA, Martinez C, Larrañaga N, Chirlaque MD, Ardanaz E, Stattin P, Hallmans G, Khaw KT, Bingham S, Slimani N, Ferrari P, Rinaldi S, Riboli E. 2007. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 86: 672-681.
20. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. 2003. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157: 335-344.
21. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, Friesen MD, Riboli E, Hayes RB. 2007. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 16: 962-968.
22. Nomura AM, Stemmermann GN, Lee J, Craft NE. 1997. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6: 487-491.
23. Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. 2011. Oxidative balance score and risk of prostate cancer: Results from a case-cohort study. Cancer Epidemiol 35: 353-361.
24. Karppi J, Kurl S, Nurmi T, Rissanen TH, Paukkal E, Nyyssönen K. 2009. Serum lycopene and the risk of cancer: The Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Ann Epidemiol 19: 512-518.
25. Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW. 2010. Serum levels of folate, lycopene, b-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr 64: 1235-1238.
26. Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM. 2011. Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev 20: 638-646.
27. Salem S, Salahi M, Mohseni M, Ahmadi H, Mehrsai A, Jahani Y, Pourmand G. 2011. Major dietary factors and prostate cancer risk: a prospective multicenter case-control study. Nutr Cancer 63: 21-27.
28. Comstock GW, Helzsouer KJ, Bush TL. 1991. Prediagnostic serum levels of carotenoids and vitamin E a related to subsequent cancer in Washington County, Maryland. Am J Clin Nutr 53: 260-264.
29. Hsing AW, Comstock GW, Abbey H, Polk BF. 1990. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82: 941-946.
30. Jenab M, Slimani N, Bictash M, Ferrari P, Bingham SA. 2009. Biomarkers in nutritional epidemiology: applications, needs and new horizons. Hum Genet 125: 507-525.
31. Stahl W, Schwarz W, Sundquist AR, Sies H. 1992. Cistrans isomers of lycopene and beta-carotene in human serum and tissues. Arch Biochem Biophys 294: 173-177.
32. Cade J, Thompson R, Burley V, Warm D. 2002. Development, validation and utilization of food-frequency questionnaires-a review. Public Health Nutr 5: 567-587.
33. Etminan M, Takkouche B, Caamano-Isorna F. 2004. The role of tomato products and lycopene in the prevention of prostate cancer: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev 13: 340-345.